Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
insitro
Biotech
AstraZeneca, insitro ink $1.5B AI-enabled target discovery deal
AstraZeneca is paying insitro $40 million upfront to find novel drug targets for liver and heart diseases using artificial intelligence.
Nick Paul Taylor
Oct 15, 2026 6:00am
Longtime Takeda R&D chief to depart next June—Chutes & Ladders
Sep 11, 2026 8:30am
Lilly invites biotechs to use AI platform to develop their drugs
Sep 9, 2025 7:43am
AI-powered Insitro taps Lilly to clear path to clinic for siRNA
Oct 9, 2024 9:28am
Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
Jan 12, 2024 9:30am
Medtech's top 10 money raisers of 2021
Mar 21, 2022 3:00am
